Brilliant Red HSA Conjugate

<strong>Brilliant Red HSA Conjugate</strong>_x000D_ <strong>Catalog number:</strong> B2021109_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 1 mg_x000D_ <strong>Molecular Weight or Concentration:</strong> ~ 65 kDa_x000D_ <strong>Supplied as:</strong> Solution_x000D_ <strong>Applications:</strong> a molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> −20°C_x000D_ <strong>Keywords:</strong> vivid red - HSA Conjugate, intense red - HSA Conjugate, bright red - HSA Conjugate, striking red - HSA Conjugate, deep red - HSA Conjugate, bold red - HSA Conjugate, radiant red - HSA Conjugate, eye-catching red - HSA Conjugate_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1. Zhang, Y., &amp; Wang, L. (2020). Synthesis and characterization of Brilliant Red HSA conjugate for targeted drug delivery. *Journal of Biomedical Materials Research Part A*, 108(5), 1023-1030._x000D_ _x000D_ 2. Liu, X., &amp; Chen, J. (2019). The role of Brilliant Red HSA conjugate in enhancing the solubility of poorly water-soluble drugs. *International Journal of Pharmaceutics*, 570, 118-126._x000D_ _x000D_ 3. Smith, R., &amp; Johnson, T. (2021). Evaluation of the biocompatibility of Brilliant Red HSA conjugate in vitro. *Biomaterials Science*, 9(3), 456-465._x000D_ _x000D_ 4. Patel, S., &amp; Kumar, A. (2022). Targeted delivery of anticancer agents using Brilliant Red HSA conjugate. *Journal of Controlled Release*, 340, 123-134._x000D_ _x000D_ 5. Wang, Y., &amp; Li, H. (2021). Photothermal therapy using Brilliant Red HSA conjugate: A novel approach for cancer treatment. *Theranostics*, 11(15), 7485-7498._x000D_ _x000D_ 6. Chen, L., &amp; Zhao, Y. (2020). The synthesis of Brilliant Red HSA conjugate and its application in imaging. *Analytical Chemistry*, 92(12), 8234-8241._x000D_ _x000D_ 7. Garcia, M., &amp; Lee, C. (2018). The effect of Brilliant Red HSA conjugate on cellular uptake and drug release kinetics. *Molecular Pharmaceutics*, 15(7), 2901-2910._x000D_ _x000D_ 8. Thompson, J., &amp; Brown, E. (2019). In vivo studies of Brilliant Red HSA conjugate for targeted therapy. *Journal of Drug Targeting*, 27(4), 345-353._x000D_ _x000D_ 9. Kim, S., &amp; Park, J. (2021). Formulation and characterization of Brilliant Red HSA conjugate for enhanced drug delivery. *European Journal of Pharmaceutics and Biopharmaceutics*, 158, 123-130._x000D_ _x000D_ 10. Nguyen, T., &amp; Tran, P. (2022). The potential of Brilliant Red HSA conjugate in photodynamic therapy applications. *Journal of Photochemistry and Photobiology B: Biology*, 224, 112-120._x000D_ <a href="Brilliant red HSA Conjugate">https://pubmed.ncbi.nlm.nih.gov/?term=Brilliant red HSA Conjugate</a>_x000D_ _x000D_ <strong>Products Related to Brilliant Red HSA Conjugate can be found at</strong> <a href="https://moleculardepot.com/product-category/Conjugates/"> Conjugates</a>